StockClub

News

Aug 11 (Tue)
P-OPEACNBC

OpenAI wraps $7 billion share sale ahead of potential IPO

OpenAI has completed a secondary share sale totaling roughly $7 billion, CNBC confirmed. The tender offer has been in the works since OpenAI closed its record-breaking $122 billion funding round in Ma

EarningsTrump Media & Technology Group Corp.DJTForbes

Trump Media Tanks 8% To 2-Week Low As Company Reports Latest Losses

We estimate President Donald Trump's net worth at $6.4 billion, falling nearly $100 million Monday. Trump's stake in the company is worth about $1 billion.

EarningsTrump Media & Technology Group Corp.DJTCNBC

Trump Media posts $238 million second-quarter loss as crypto declines

Trump Media & Technology Group reported a net loss of more than $238 million in its fiscal second quarter on revenue of less than $2 million. TMTG said its loss was largely due to declines in "digital

OtherP-RIPLNew York Post

Rippling hits back at NYC AI startup's trade secret lawsuit in messy legal battle

“It takes a certain boldness to accuse a competitor of violating intellectual property laws while infringing on that competitor's inventions. But that's exactly what Runlayer has done here,” a spokesp

OtherGoDaddy Inc.GDDYPRNewsWire

Rosen Law Firm Encourages GoDaddy Inc. Investors to Inquire About Securities Class Action Investigation - GDDY

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoDaddy Inc. (NYSE: GDDY) r

The Ensign Group, Inc.ENSGPRNewsWire

Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NAS

Dnow Inc.DNOWNewsfile Corp

ROSEN, A LEADING LAW FIRM, Encourages DNOW Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - DNOW

New York, New York--(Newsfile Corp. - August 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of all persons or entities who

Sponsored
EarningsDATA Communications Management Corp.DCMDFNewsfile Corp

DATA Communications Management Corp. Reports Q2 2026 Financial Results

Brampton, Ontario--(Newsfile Corp. - August 10, 2026) - DATA Communications Management Corp. (TSX: DCM) (OTCQX: DCMDF) ("DCM" or the "Company"), a leading Canadian provider of print and digital soluti

OtherNintendo Co., Ltd.NTDOYSeeking Alpha

Nintendo: Console Transition Year, But Software Coming To Assert Itself In Mix

Nintendo (NTDOY) delivers strong operating profit growth, driven by Super Mario movie success, software mix shift, and tariff refunds. Software sales and IP monetization are increasingly central, with

Seeking Alpha

The S&P Is Ignoring Semiconductor Crashes

Semiconductor selloffs stopped dragging the S&P 500 this year. I don't think chip volatility is a threat to the broad market anymore.

Newsfile Corp

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages FLOW Cryptocurrency Investors to Inquire About Securities Class Action Investigation

New York, New York--(Newsfile Corp. - August 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of investors in FLOW (FL

Ryder System, Inc.RNewsfile Corp

Theralase(R) Announces $5 Million Brokered LIFE Offering

Toronto, Ontario--(Newsfile Corp. - August 10, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the

Capgemini SECAPMFSeeking Alpha

CapGemini: Part Of The IT Upside (Albeit A Slow One)

CapGemini is fundamentally undervalued, trading at less than 8.6x P/E with a 12% earnings yield and a 3.1% well-covered dividend. Recent 1H26 results show stable revenues, growing operating margins (1

ProductCerebras Systems Inc.CBRSSeeking Alpha

Cerebras Systems Long-Term View: Delivery Speed Is The Next Frontier Of AI

Cerebras Systems Inc. leads AI inference hardware with its WSEs, offering unmatched token generation speed and a strong first-mover advantage. CBRS's WSE-3 delivers 7,000x the bandwidth of Nvidia's H1

Sponsored
OtherIntuit Inc.INTUPRNewsWire

APPROACHING DEADLINE ALERT: Intuit Inc. (INTU) Securities Fraud Class Action Lawsuit Filed; September 8, 2026, Lead Plaintiff Deadline

Did you buy INTU securities between August 22, 2025 and May 20, 2026? Affected INTU Investor Summary Who: Intuit Inc. (NASDAQ: INTU) What: Securities fraud class action lawsuit filed Class Period: Aug

OtherAvis Budget Group, Inc.CARPRNewsWire

CAR Investors Have Opportunity to Lead Avis Budget Group, Inc. Securities Fraud Lawsuit Against Pentwater Capital Management LP

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Avis Budget Group, Inc. (NASDA

MacroCNBC

Trump says he spoke recently to Fed Chairman Warsh, denies regular calls

President Donald Trump said Monday that he and Fed Chair Kevin Warsh spoke "one time, briefly, a few days ago." Trump denied an earlier news report that said the two men had spoken repeatedly since Wa

AnalystMicron Technology, Inc.MUProactive Investors

Micron poised for "structural reset" in earnings power, UBS says, as HBM squeeze tightens further

Micron Technology Inc (NASDAQ:MU)'s earnings power looks headed for a structural reset, according to UBS, which pointed to memory supply so tight that Nvidia was forced to de-spec its upcoming VR300 G

OtherLockheed Martin CorporationLMTPRNewsWire

Lockheed Martin Announces Successful Static-Fire Test of Next Generation Interceptor's Stage 2 Motor

HUNTSVILLE, Ala., Aug. 10, 2026 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) has announced the Stage 2 rocket motor for the Next Generation Interceptor (NGI) program has successfully completed a static

ProductKodiak Sciences Inc.KODPRNewsWire

Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema

Phase 3 ALTO trial designed to demonstrate superiority of KSI-501 versus aflibercept in patients with diabetic macular edema PALO ALTO, Calif., Aug. 10, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasd